Researchers Identified New Genes Linked to Disc Degeneration

Scientists have isolated four candidate genes that may influence the progression of chronic low back pain.

Updated on Oct. 5, 2026 in Arthritis

Bold vector editorial illustration of a single intervertebral disc structure in teal and sage, clean and anatomical.
Researchers have identified four candidate genes that may influence the progression of chronic intervertebral disc degeneration and low back pain. AI Illustration. Upload story photo >

Researchers have identified four candidate genes—AHR, UACA, GCLM, and GSTZ1—that appear to play a role in intervertebral disc degeneration. This development could help better assess the severity of this condition, which is a leading pathological cause of chronic low back pain.

Why it matters

Reliable molecular indicators for grading the severity of disc degeneration have historically been scarce. Identifying these specific genes allows for a more targeted approach to understanding the biological drivers of chronic back pain.

Using a dataset of 553 differentially expressed genes, researchers identified 65 metabolic reprogramming-related genes. The study utilized LASSO-penalized regression and random forest algorithms, with validation performed via RT-qPCR in human nucleus pulposus cells.

The details

Researchers focused on metabolic reprogramming, a process where cells alter their metabolism to survive or adapt to stress. By identifying the AHR, UACA, GCLM, and GSTZ1 genes, the team created a nomogram to predict the severity of disc degeneration. Higher metabolic reprogramming scores were linked to more advanced stages of the disease, suggesting these genes are central to how disc cells deteriorate over time.

Timeline

  1. October 5, 2026: The study was published.

Health Landscape

This research contributes to the growing effort to move beyond symptomatic diagnosis of back pain toward molecular profiling. It follows the pattern established by studies using the GSE70362 dataset to define the genetic underpinnings of musculoskeletal conditions.

While this study provides new insight into the biological causes of back pain, it does not change current clinical treatment or self-care protocols. Patients experiencing chronic low back pain should continue to discuss symptom management and appropriate diagnostic testing with their physician.

The takeaway

Understanding the genetic drivers of disc degeneration is a significant step toward more precise diagnosis of chronic back pain. Readers should monitor their pain patterns and consult a doctor regarding any persistent discomfort that interferes with daily activity.

Further reading

For more information on chronic pain management, visit our Arthritis section.

Source note: This article includes information reported by Nature.